Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$0.85 - $1.43 $136,000 - $228,800
160,000 Added 7.21%
2,380,000 $2.19 Million
Q2 2023

Aug 14, 2023

BUY
$1.12 - $1.49 $118,910 - $158,193
106,170 Added 5.02%
2,220,000 $2.64 Million
Q1 2023

May 12, 2023

BUY
$1.19 - $2.19 $135,457 - $249,287
113,830 Added 5.69%
2,113,830 $3.17 Million
Q4 2022

Feb 14, 2023

BUY
$1.07 - $1.34 $525,905 - $658,610
491,500 Added 32.58%
2,000,000 $2.42 Million
Q2 2022

Aug 15, 2022

BUY
$1.13 - $3.69 $1.7 Million - $5.57 Million
1,508,500 New
1,508,500 $2.25 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $177M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Price Jennifer C. Portfolio

Follow Price Jennifer C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price Jennifer C., based on Form 13F filings with the SEC.

News

Stay updated on Price Jennifer C. with notifications on news.